• Keine Ergebnisse gefunden

Table S1. Measurement of glutamate and GABA in

N/A
N/A
Protected

Academic year: 2022

Aktie "Table S1. Measurement of glutamate and GABA in"

Copied!
5
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Table S1. Measurement of glutamate and GABA in Levilactobacillus brevis Lbr-6108, Lbr-35, and ATCC 14869. The p-value is the result of an ANOVA with Tukey's multiple comparison test comparing the ODs of each strain to at T48 to Lbr-6108 in the respective media.

StrainTimepoint (hr)rep 1rep 2rep 1rep 2rep 1rep 2p-valuerep 1rep 2rep 1rep 2rep 1rep 2p-valueLbr-6108066067050500.1390.1418900880050500.1370.133Lbr-6108365064050500.4340.4329000860060580.4120.397

Lbr-6108662059066700.6670.671860086001001000.6150.602Lbr-610895705102101901.0561.069870085003103200.9590.968Lbr-6108123603503403501.2911.320810081006206301.2171.226Lbr-6108151301205005201.4781.44872007600120012001.4061.386Lbr-6108181001005005001.6381.61163006300190020001.5421.540Lbr-6108211001005005001.7671.76350005100280028001.6891.722Lbr-6108241001005005001.8161.83337003700400038001.7891.774Lbr-6108481001005005101.7331.753250300600060001.7241.733Lbr-35069067050500.1420.1368900880053500.1450.139Lbr-35368066050500.5190.5008900900050500.4760.491

Lbr-35667064050500.8550.8498800860050500.7800.753Lbr-35967070054591.0861.1108600890076701.0291.021Lbr-351271068058501.2781.2718600900061561.1591.144Lbr-351569068050511.4461.3978800890075601.2661.278Lbr-351868069051521.5561.5448700890063631.3971.401Lbr-352167068054581.6501.6878900950071721.5021.564Lbr-352463060082801.7411.738870088001201101.5661.579Lbr-35485605401701601.6901.690>0.9999900089002702301.6351.621>0.9999 glutamate, MRS (μg/mL)Glutamate, MRS+MSGg/mL)GABA, MRS (μg/mL)OD, MRS (μg/mL)GABA, MRS+MSGg/mL)OD, MRS+MSG (600nm)

(2)

Table S2. Glutamate utilization and GABA production by Levilactobacillus brevis Lbr-6108 in MRS with different concentrations of MSG.

Timepoint (hr)rep 1rep 2rep 1rep 2rep 1rep 2rep 1rep 2rep 1rep 2rep 1rep 2rep 1rep 2rep 1rep 2rep 1rep 25500.0450.050.050.010.0%11.1%1000.0340.050.050.05.0%14.7%5000.04740.050.050.01.0%1.1%244200.04290.02600.02620.061.9%61.1%6000.05920.02900.02930.048.3%49.5%4000.03790.01800.01830.045.0%48.3%488200.08160.05300.05310.064.6%65.1%16300.016270.010000.09970.061.3%61.3%24000.023530.013000.012680.054.2%53.9%728000.07980.06100.06075.076.3%76.1%18200.018405.012000.012140.065.9%66.0%28000.023530.016000.016450.057.1%69.9% MRS with 10,000 μg/mL MSGMRS with 30,000 μg/mL MSGMRS with 90,000 μg/mL MSGGlu Uptakeg/mL)GABAg/mL)% YieldGlu Uptakeg/mL)GABAg/mL)% YieldGlu Uptakeg/mL)GABAg/mL)% Yield

(3)

Table S3. Gene List from Figure 4. Locus IDs are for Levilactobacillus brevis Lbr-6108 genome.

Encoded protein functions are given for genes shown in Figure 4.

Locus ID Gene

name Protein function Operon / pathway

Panel in Figure

4

BGC39_04180 gadA Glutamate decarboxylase (EC 4.1.1.15) GadA

L-Glutamate decarboxylase

operon A

BGC39_07245 gadR Transcriptional regulator GadR

L-Glutamate decarboxylase

operon A

BGC39_07250 gadC Glutamate/gamma- aminobutyrate antiporter

L-Glutamate decarboxylase

operon A

BGC39_07255 gadB Glutamate decarboxylase (EC 4.1.1.15) GadB

L-Glutamate decarboxylase

operon A

BGC39_07260 gltX Glutamyl-tRNA synthetase (EC 6.1.1.17; EC 6.1.1.24)

L-Glutamate decarboxylase

operon A

BGC39_05810 hmpT

Substrate-specific component HmpT of predicted

hydroxymethylpyrimidine ECF transporter

Pyridoxal 5’-phosphate (PLP) B

BGC39_05815 thiD2 Novel pyridoxal kinase, thiD

family (EC 2.7.1.35) Pyridoxal 5’-phosphate (PLP) B

BGC39_05820 norD

Transcriptional regulator of pyridoxine metabolism / Pyridoxamine phosphate aminotransferase (EC 2.6.1.54)

Pyridoxal 5’-phosphate (PLP) B

BGC39_05050 argF

Ornithine

carbamoyltransferase (EC 2.1.3.3)

Arginine deiminase operon C BGC39_05055 arcA Arginine deiminase (EC

3.5.3.6) Arginine deiminase operon C

BGC39_05060 arcD Arginine/ornithine antiporter

ArcD Arginine deiminase operon C

BGC39_06170 aguA Agmatine deiminase (EC

3.5.3.12) Agmatine deiminase operon D

BGC39_06175 aguD

Agmatine/putrescine antiporter, associated with agmatine catabolism

Agmatine deiminase operon D

BGC39_06180 aguB

Putrescine

carbamoyltransferase (EC 2.1.3.6)

Agmatine deiminase operon D

(4)

BGC39_06135 mleS Malolactic enzyme (EC

4.1.1.101) Malolactic fermentation operon E BGC39_06140 mleR Malolactic regulator MleR Malolactic fermentation operon E BGC39_06185 nhaC2 Predicted tyrosine transporter,

NhaC family Tyrosine decarboxylase operon F BGC39_06190 tdcP Predicted tyrosine transporter,

GadC family Tyrosine decarboxylase operon F BGC39_06195 tdcA L-tyrosine decarboxylase (EC

4.1.1.25) TDC Tyrosine decarboxylase operon F BGC39_06200 tyrS Tyrosyl-tRNA synthetase (EC

6.1.1.1) Tyrosine decarboxylase operon F

(5)

Figure S1. Culture purity testing by species- and strain-specific PCR for Levilactobacillus brevis Lbr-6108 and Lbr-35.

Figure S2. PCA plot of RNA-sequencing for Levilactobacillus brevis Lbr-6108 and Lbr-35.

Referenzen

ÄHNLICHE DOKUMENTE

The later result, together with the weak pecking-impairing effects of this small dose during training and in experiment 11, when co-administered with apomorphine, suggests that

[r]

Some transmitters like acetylcholine will be enzymatically inactivated in the synaptic cleft to ensure a short pulse duration, others like glutamate or dopamine will

Comparing MCTP and the global testing procedure ANOVA, one notices that both procedures can be used to test the global null hypothesis H 0.. From a practical point of view,

Ryder (1975) applied what we now call ∝ -ages to show how the chronological age at which people became elderly changes in stationary populations with different life

Scenario 3 demonstrated that the merger of a relatively poor (in terms of income per capita) two-individual population with a relatively rich (in terms of

Using proteoliposomes containing VGLUT1 and a bacterial proton pump they observed dramatically enhanced glutamate uptake in presence of high luminal chloride [21].. In this system

Besides the alterations of presynaptic neural activity, changes in glutamate receptor complex composition are implicated in long-term changes of synaptic structure and